Table 77Patient flow through trials–haloperidol versus olanzapine

Intervention #1Intervention #2Intervention #3Intervention #4Intervention #5Intervention #6
Moreno et al. 2007119ClassificationFGAFGA
MedicationHaloperidolOlanzapine
Dosage3–15mg/d5–20mg/d
No screened:19
No randomized:57
No completed:57
No analyzed (E):57
No analyzed (S):57
Tohen et al. 2003140ClassificationFGAFGA
MedicationHaloperidolOlanzapine
Dosage3–15mg/d5–20mg/d
No screened:498
No randomized:219234
No completed:116140
No analyzed (E):219234
No analyzed (S):219234

d = day; E = efficacy; FGA = first-generation antipsychotic; mg = milligram; No = number; NR = not reported; S = safety; SGA = second-generation antipsychotic

From: Appendix I, Patient Flow Through Trials

Cover of First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness [Internet].
Comparative Effectiveness Reviews, No. 63.
Abou-Setta AM, Mousavi SS, Spooner C, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.